Presentation is loading. Please wait.

Presentation is loading. Please wait.

Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial  Dr.

Similar presentations


Presentation on theme: "Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial  Dr."— Presentation transcript:

1 Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial  Dr Rosalind Parkes-Ratanshi, PhD, Katie Wakeham, MRCP, Prof Jonathan Levin, PhD, Deodata Namusoke, MA, James Whitworth, PhD, Alex Coutinho, MPH, Nathan Kenya Mugisha, MPH, Prof Heiner Grosskurth, PhD, Anatoli Kamali, MSc, Prof David G Lalloo, FRCP  The Lancet Infectious Diseases  Volume 11, Issue 12, Pages (December 2011) DOI: /S (11) Copyright © 2011 Elsevier Ltd Terms and Conditions

2 Figure 1 Trial profile The Lancet Infectious Diseases  , DOI: ( /S (11) ) Copyright © 2011 Elsevier Ltd Terms and Conditions

3 Figure 2 Incidence of cryptococcal disease by treatment group
The Lancet Infectious Diseases  , DOI: ( /S (11) ) Copyright © 2011 Elsevier Ltd Terms and Conditions


Download ppt "Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial  Dr."

Similar presentations


Ads by Google